Clinical Trial Update: Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adalimumab in adults with moderate to severe chronic hidradenitis suppurativa reported results. Results were posted on May 9, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Abbott | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2011-05-09